HERNANDEZ MIRAMONTES JORGE ANTONIO,HERNANDEZ VILLANUEVA JORGE ALBERTO
申请号：
CL2017001262
公开号：
CL2017001262A1
申请日:
2017.05.17
申请国别(地区):
CL
年份:
2017
代理人:
摘要：
At present, the treatment of patients with advanced nephropathy (the fifth Stadium) includes alternative renal therapy (hemodi amp； Aacute； LISIS, DI amp； Aacute； lysine peritonitis or kidney transplantation)；EXTRAORDINARLY COSTABLE THAT CONLIVES A POOR QUALITY OF LIFE. OUR INVENTION IS A MIXTURE OF CARBOXIacute； LICOS: Aacute； SCIENTIFIC CIDO； Aacute； SUCCINIC ACID； SUCH PRODUCT IS PREFERREDLY USED BY ORAL OR ALSO VIA INTRAVENOUS, IN THE TREATMENT OF PATIENTS WITH CROAcute； RENAL INSUFFICIENCY,HYPERAMONEMY OR HUMAN CONDITIONS COURSEING WITH NEGROTIVE NITROGEN BALANCE. THIS PRODUCT IS BEAUTIFUL TO DECREASE THE SECRET VALUES OF UREA AND SEAcute AMONIUM； AT THE TIME THAT BY TRANSAMINATION OF THE FORMED OXALACETATE VIacute； TO SUCCINATE, FUMARATE AND MALATE, PROMOTES THE BIOSISATION； NON ESSENTIAL CIDES； BY TRANSAMINATION OF THE ALFA CETO GLUTARATE FORMED VIacute； A CITRATE, GENERATES AUCTION GLUTAATIC； MICO AND THE AMINOAacute； CIDS RELATED TO THE SAME AS GLUTAMINE. THIS TREATMENT PREVENTS,It saves and even improves functions and amperes. Among other patients, hypofunction, oacute, n-hyponephrosis and the urgent need for alternative renal treatment were delayed. In other M amp； Aacute； s, alternative kidney therapy is used as complementary therapy to improve the quality of life of patients and improve the balance between double room and double room； Aacute； experimental meter； lt； / P gt；<；p>；ACTUALMENTE EL TRATAMIENTO PARA PACIENTES CON ENFERMEDAD RENAL TERMINAL (ESTADIO V) CONSISTE EN TERAPIA RENAL SUSTITUTIVA (HEMODIÁ；LISIS, DIÁ；LISIS PERITONEAL O TRASPLANTE RENAL)； EXTRAORDINARIAMENTE COSTOSA QUE CONLLEVA UNA POBRE CALIDAD DE VIDA. NUESTRO INVENTO ES UNA MEZCLA DE Á；CIDOS CARBOXÍ；LICOS: Á；CIDO CÍ；TRICO, Á；CIDO SUCCINICO, Á；CIDO FUMÁ；RICO Y Á；CIDO MÁ；LICO, Y CUALESQUIERA DE SUS COMBINACIONES POSIBLES. DICHO PRODUCTO SE UTILIZA PREFERENTEMENTE VÍ；A ORAL O TAMBIÉ；N VIA INTRAVENOSA,
